Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development

Nina Jain; Thomas Hwang; Jessica M Franklin; Aaron S Kesselheim

doi:10.1001/jama.2017.7467

Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development

JAMA. 2017 Jul 25;318(4):388-389. doi: 10.1001/jama.2017.7467.

Authors

Nina Jain¹, Thomas Hwang¹, Jessica M Franklin¹, Aaron S Kesselheim¹

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.

Abstract

This study uses commercial pharmaceutical database data to evaluate the number of new drugs and vaccines for neglected tropical diseases entering phase 1 clinical trials before and after introduction in 2007 of a priority review voucher program to incentivize development.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Clinical Trials, Phase I as Topic / statistics & numerical data
Drug Industry
Financing, Government
Humans
Orphan Drug Production / legislation & jurisprudence
Orphan Drug Production / statistics & numerical data*
Tropical Medicine*
United States